MicroRNA-21 (miR-21) has been identified as the best hit in a number of medium-scale and high-scale profiling experiments designed for the detection of miRNAs dysregulated in cancer. The first indication of miR-21's aberrant expression came from the miRNA profiling of human glioblastoma (GBM),
miR-21 is also strongly upregulated in Epstein-Barr virus-infected human B lymphocytes [16] and hepadnavirus-associated hepatocellular carcinoma [17], suggesting the possibility that it is also involved in viral infections and virus-linked proliferative disorders. Interestingly, high levels of miR-21 may not only characterise cancer cells but also represent a common feature of pathological cell growth or cell stress. For example, miR-21 is up-regu-
lated in several models of mouse hypertrophic heart including thoracic aortic banding, which induces hypertrophy by increased afterload on the heart, and in transgenic mice expressing constitutively active calcineurin A in the heart muscle, which results in a severe, well-characterised form of hypertrophy [18] [19] [20] . It is also elevated in vascular walls after balloon injury, a model of vascular neointimal lesion formation [21] . One group also demonstrated a five-fold up-regulation in hypertrophic left cardioventricular tissue from human patients with end-stage systolic heart failure [22] . In vitro, miR-21 was the most upregulated miRNA in cultured rat neonatal cardiac myocytes stimulated with the hypertrophic agents angiotensin II and phenylephrine [18] . [18] . Downregulation of aberrantly expressed miR-21 also reduces neointima formation in rat carotid artery after angioplasty by affecting both proliferation and apoptosis of vascular smooth muscle cells (VSMCs) [21] . Conversely, miR-21 overexpression by its synthetic mimics transfected in cultured cardiomyocytes in combination with miR-212 and miR-129 mimics modified a set of foetal cardiac genes and led to the development of cellular hypertrophy [22] . In contrast, a study by Tatsuguchi et al. [19] suggests that miR- 21 [23] [24] [25] . It is also induced in adherent mammosphere cultures differentiating on collagen [26] .
While there is a good agreement among independent studies of miR-21 expression in hypertrophic heart and vasculature, the data regarding its functional effects obtained by several groups appear more controversial. For example, inhibition of endogenous miR-21 by antisense 2ЈO-Me molecules slows down the hypertrophic growth in a model of induced hypertrophy in cultured cardiomyocytes

has a subtle yet reproducible inhibitory effect on cardiac hypertrophy, whereas LNA-based miR-21 inhibitors may induce hypertrophy. Regardless of its role, miR-21 is clearly up-regulated in cardiac hypertrophy and in a variety of other human proliferative disorders, implying a function in regulating cell growth. This idea is further supported by evidence of miR-21 induction associated with cellular dedifferentiation. An interesting example is the restricted thyroid cell line FRTL-5 that depends on the presence of thyroid-stimulating hormone (TSH). Oncogenic Ras induction leads to dedifferentiation and TSH-independent proliferation of the thyroid cells and up-regulation of miR-21 after 7 days from 0.3% to 11% total miRNA content [15]. Ras-induced expression of miR-21 can be mediated through signal transducer and activator of transcription (STAT3) and/or SMADs signalling (see the next section). The understanding of this subject
One interesting observation was made by Fujita [25] [25, 27] . Common up-regulation of miR-21 expression in cancer led us to examine the possible amplification of this genomic locus in cancer.
The amplification of the 17q chromosomal region is associated with a number of cancers, including breast [28] and prostate cancer [29] , and occurs in ~50% of medulloblastoma cases [30] . The 17q region has also been associated with frequent gains in Hodgkin lymphoma [31] . However, the genomic locus encoding miR-21 is not amplified in most cancers including those expressing very high levels of miR-21, such as GBM and CLL [11, 32] [25] .
An analysis of the consensus sequences within the miR-21 promoter region identified several conserved enhancer elements (Fig. 1 
Post-trancriptional regulation
A recent study of TGF-␤-and BMP-induced miR-21 expression in
VSMCs has revealed additional mechanisms that control miR-21 processing, which again makes this molecule outstanding [42] [50] . Elevation of miR-21 using an expression vector significantly promoted survival and reduced cytokine dependency of myeloma cells [36] . Enhanced miR-21 expression by transfection with precursor miR-21 increased tumour cell proliferation, migration and invasion in cultured human hepatocellular cancer cells [51] and invasion of colon cancer cells [52] . Conversely, inhibition of miR-21 expression by various ASOs reduced anchorage-independent colony formation, proliferation and invasion while inducing apoptosis of hepatocellular carcinoma cells [17, 51] . In addition, reduced proliferation and tumour growth of MCF7 breast cancer cells [53, 54] , motility and invasiveness of glioma [49] and invasion, intravasation and metastatic capacity of colon cancer cells [52] Table 1 ). [53, 60] , colorectal cancer [52] and glioma [49] , as well as in a murine JB6 epidermal model of neoplastic transformation [50] . Reduced PDCD4 expression has been reported in at least six human tumour types or cancer cell lines (lung, brain, renal, breast, colon and pancreas) [61] [62] [63] [64] in which miR-21 is overexpressed [1, 3, [65] [66] [67] [42] . [68, 69] , PDCD4 was further characterised as a potent tumour suppressor. PDCD4 inhibits PMAinduced neoplastic transformation [70] and tumour promotion and progression [71] and inhibits invasion and intravasation [72] . It is down-regulated in a number of cancers, and its suppression in lung and colorectal cancers is associated with poor patient prognosis [61, 73] . PDCD4 interacts with translation initiation factors eIF4A and eIF4G and inhibits translation initiation by displacing eIF4G and RNA from eIF4A [74] [75] [76] . Specific molecules regulated by PDCD4 include p21 [77] , Cdk4, ornithine decarboxylase [71] , carbonic anhydrase II [78] and JNK/c-Jun/AP-1 [79, 80] . [81, 82] . Its expression level is also an important prognostic factor for multiple cancer types [83] . miR-21 regulation of RECK expression was detected in glioma and osteoblastoma cancer cells [49] [25] and glioma [49] . [58] [52] and VSMCs [21] , but not in the MCF-7 breast cancer [53] , A549 non-small cell lung cells [88] or glioma cells [49] [89, 90] . [91] , and our data suggest that these effects can be at least partly due to miR-21 regulation, in addition to the reported chromosome 12q22-23 LOH and hypermethylation [91] . Overexpression of APAF1 by viral transduction could induce apoptosis in glioma cells and may be beneficial in glioma treatment [92] . STAT3, the other gene that may have a tumour suppressor function in GBM [93] , is also negatively regulated by miR-21, according to the microarray data, and is a predicted miR-21 target [49, 57, 94] [95, 96] , is also extensively regulated by miR-21 in glioma and MCF7 breast cancer and U2OS osteobastoma cells [49] . Though [49] . It is also worth noting that miR-21 inhibition leads to the reduced expression of several critical oncogenes, including MYC, Jun, RELB and LIF, and MYC reduction was also detected by a similar analysis performed on breast cancer MCF7 cells [53] . Therefore, it appears that multiple critical proteins associated with the glioma cell cycle, apoptosis and invasion, rather than a single signalling pathway, are regulated by miR-21.
inhibition). Both mRNA and protein analyses have been utilised for identification of miR-21 targets, resulting in tropomyosin 1 (TPM-1) identified by proteomics and programmed cell death protein 4 (PDCD4), and reversioninducing cysteine-rich protein with kazal (RECK) motifs by mRNA arrays. Below, we briefly describe validated miR-21 direct targets that meet at least the following criteria: (i) their expression correlates inversely with miR-21 levels and activity (i.e. increased in antimiR-21-treated cells and reduced in miR-21-overexpressing cells); (ii) they have miR-21 binding site(s) with a complementary seed and are capable of directly binding to miR-21, as detected in a luciferase reporter assay. The luciferase constructs with a target 3ЈUTR are specifically responsive to miR-21 overexpression or anti-miR-21 treatment (or both). Finally, deletion or mutation of the miR-21 binding site from the 3ЈUTR abolishes the miR-21 regulation (the targets are summarized in
PDCD4 is one of the principal miR-21 targets validated independently by several groups. It has a single highly conserved miR-21 target site within its 3ЈUTR, and its regulation by miR-21 has been reported in a number of human cancer cells including breast cancer
, indicating that miR-21-PDCD4 is likely to be a clinically significant oncogene/tumour suppressor pair in the induction and progression of human carcinomas. PDCD4 is also a functional target of miR-21 involved in the BMPmediated induction of smooth muscle cell markers in the differentiation of vascular smooth muscle cells
Initially discovered as a gene that is up-regulated in apoptosis in response to a number of inducers
RECK is a membrane-anchored inhibitor of metalloproteinases (MMPs) whose reduced expression or inactivation seems to be critical for the invasiveness and metastasis of various cancers, including glioma
and gastric cancers [5]. In glioma, RECK appears to be a principal target that mediates miR-21 invasiveness and possibly angiogenesis by inhibiting activities of MMP-2, MMP-9 and other MMPs. Interestingly, RECK also appears as the major miR-21 target and MMP regulator in mouse uterus during embryo implantation and in endometrial adenocarcinoma Ishikawa cells [84]. Therefore, miR-21 may be a key regulator of normal cell motility and invasiveness during developmental processes (e.g. blastocyst implantation), as well as of cancer cell invasiveness. Another recently identified miR-21 target, perhaps more confined to several cell types, is mammary serine protease inhibitor or maspin [60], a non-inhibitory serpin with tumour-suppressive properties. The molecular mechanisms underlying maspin's proapoptotic, anti-angiogenic and anti-metastatic functions are diverse [85]: transcriptional control by regulation of chromatin remodelling activities and direct interactions with transcription factors, regulation of GSH redox system and thus maintaining cellular homeostasis and responding to cellular stress and regulation of integrin profile and invasiveness of the cell. So far, miR-21 regulation of maspin expression has been demonstrated exclusively in metastatic breast MDA-MB-231 cells. NFIB, a phylogenetically conserved miR-21 target, is a member of the NFI gene family, often functioning as a versatile transcriptional repressor of many promoters either through competition with other transcriptional factors for binding or through changes in the nucleosome structure. This protein is essential for lung maturation and brain development, but its function in cancer is not well studied yet. miR-21 regulation over NFIB mRNA has been demonstrated in HCT-116 colon carcinoma, HL-60 myeloid cells
Tropomyosin 1 (TPM1), a protein with potential of suppressing cell growth and invasiveness of breast carcinoma, is the only miR-21 target identified in the analysis of MCF-7 tumours by a proteomics approach
APAF1 3ЈUTR contains a strong miR-21 binding site (9-mer binding at miR-21 5Ј end), and therefore it is likely one of the direct miR-21 targets. In gliomas, APAF1 is often inactivated or down-regulated
. TIMP3, a tissue inhibitor of MMPs that inhibits angiogenesis and tumour cell infiltration and induces apoptosis
miR-21 networking and feedback regulation
Interestingly, miR-21 seems to be involved in a number of positive and negative feedback loops, and therefore is a part of the complex regulatory network operating in both normal and diseased cells (Fig. 2) [1, 49] . In breast cancer, miR-21 overexpression correlates significantly with advanced clinical stage, lymph node metastasis and patient's poor prognosis [98] . miR-21 expression is significantly higher in colon adenocarcinomas than in their precursor stage adenomas and correlates with the adenoma staging [99] and the development of metastasis [100] . Moreover, in a large study performed by Schetter et al. [99] [54] . In a study of miRNA effects on drug response performed on three cancer cell lines (non-small lung A549, glioma SNB19 and ovarian OVCAR3), the effects were most prominent for miR-21, whose levels significantly shifted the growth-inhibitory activity of 6 out of 10 compounds tested [88] 
